Ocular activity of topically administered anandamide in the rabbit

被引:32
作者
Mikawa, Y
Matsuda, S
Kanagawa, T
Tajika, T
Ueda, N
Mimura, Y
机构
[1] UNIV TOKUSHIMA,SCH MED,DEPT OPHTHALMOL,TOKUSHIMA 770,JAPAN
[2] UNIV TOKUSHIMA,SCH MED,DEPT BIOCHEM,TOKUSHIMA 770,JAPAN
关键词
anandamide; cannabinoid; intraocular pressure; rabbit;
D O I
10.1016/S0021-5155(97)00050-6
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Marijuana and its psychoactive constituents, cannabinoids, reduce intraocular pressure (IOP) in humans and animals. Because anandamide, a recently discovered endoge nous ligand of cannabinoid receptors, reportedly shows cannabimimetic pharmacological activity, we examined its effect on the eye. Varying amounts of anandamide, in 50 mu L of light mineral oil, were topically applied to a rabbit eye and changes in IOP and ocular symptoms were monitored. Anandamide (50 mu g to 1 mg) induced a significant decrease in IOP within 1 hour after administration; maximum reduction occurred at 2 hours; and there was a return to baseline by 7 hours following administration. A noticeable hyperemia of conjunctival blood vessels was also noted 2 hours after administration. Neither mineral oil alone or with palmitylethanolamide (an analogue of anandamide) caused a significant decrease in IOP or conjunctival hyperemia. This study indicates that anandamide does produce cannabimimetic effects in rabbit eyes. (C) 1997 Japanese Ophthalmological Society.
引用
收藏
页码:217 / 220
页数:4
相关论文
共 23 条
[1]   PROSTAGLANDINS AND CANNABIS .3. INHIBITION OF BIOSYNTHESIS BY ESSENTIAL OIL COMPONENTS OF MARIHUANA [J].
BURSTEIN, S ;
VARANELLI, C ;
SLADE, LT .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (09) :1053-1054
[2]   ENZYMATIC-SYNTHESIS AND DEGRADATION OF ANANDAMIDE, A CANNABINOID RECEPTOR AGONIST [J].
DEUTSCH, DG ;
CHIN, SA .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (05) :791-796
[3]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[4]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[5]  
DEWEY WL, 1986, PHARMACOL REV, V38, P151
[6]   ANANDAMIDE, AN ENDOGENOUS CANNABINOMIMETIC EICOSANOID - KILLING 2 BIRDS WITH ONE STONE [J].
DIMARZO, V ;
FONTANA, A .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1995, 53 (01) :1-11
[7]   ANANDAMIDE, AN ENDOGENOUS CANNABIMIMETIC EICOSANOID, BINDS TO THE CLONED HUMAN CANNABINOID RECEPTOR AND STIMULATES RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION [J].
FELDER, CC ;
BRILEY, EM ;
AXELROD, J ;
SIMPSON, JT ;
MACKIE, K ;
DEVANE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7656-7660
[8]   PHARMACOLOGICAL ACTIVITY OF THE CANNABINOID RECEPTOR AGONIST, ANANDAMIDE, A BRAIN CONSTITUENT [J].
FRIDE, E ;
MECHOULAM, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (02) :313-314
[9]   MOLECULAR-CLONING OF A HUMAN CANNABINOID RECEPTOR WHICH IS ALSO EXPRESSED IN TESTIS [J].
GERARD, CM ;
MOLLEREAU, C ;
VASSART, G ;
PARMENTIER, M .
BIOCHEMICAL JOURNAL, 1991, 279 :129-134
[10]   CANNABINOID ACTION ON EYE AS MEDIATED THROUGH CENTRAL NERVOUS-SYSTEM AND LOCAL ADRENERGIC ACTIVITY [J].
GREEN, K ;
BIGGER, JF ;
KIM, K ;
BOWMAN, K .
EXPERIMENTAL EYE RESEARCH, 1977, 24 (02) :189-196